FDA Lifts Ban on Juul E-Cigarettes
The US Food and Drug Administration (FDA) has rescinded its marketing denial orders for Juul Labs products, allowing the company to continue selling its e-cigarettes while the agency reviews new court decisions and updated information provided by Juul. This reversal follows the FDA's June 2022 order that initially banned Juul's products due to insufficient evidence regarding their toxicological profile. Juul products have remained on shelves pending appeal and the company's status as the No. 2 e-cigarette maker in the US has been maintained.
The FDA emphasized that the current status does not guarantee that Juul's products will ultimately be cleared for full marketing. Juul expressed confidence in the quality and substance of its applications and believes that a thorough review will demonstrate their products meet public health standards. Meanwhile, the American Lung Association has expressed disappointment with the FDA's decision and has called for the complete withdrawal of all Juul products. The FDA has reiterated that all e-cigarette products must have FDA authorization to be legally marketed.
